Home

James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 24/02/21

Trade details

Type
Insider sale
Amount
$152,408.71
Shares · price
1,913 sh · $79.67 a share
Held after
57,371 sh
Trade date
24/02/20
Filed
24/02/21
Days to filing
1 days

Sold 3.2% of holdings

Share of holding sold
3.2%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/21~24/03/21

James R. Kasinger's recent trades

  • James R. Kasinger

    Sell10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/24

  • James R. Kasinger

    Planned sale10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/22

  • James R. Kasinger

    SellCrispr Therapeutics

    $148.9K

    Filed 03/24

  • James R. Kasinger

    SellCrispr Therapeutics

    $166.5K

    Filed 03/17

  • James R. Kasinger

    SellCrispr Therapeutics

    $147.8K

    Filed 03/12